ProCE Banner Activity

Antibody–Drug Conjugates in EGFR-Mutated NSCLC

Slideset

Downloadable slides from a live satellite symposium on the use of HER3-targeted ADCs in the management of EGFR-mutated NSCLC.

Released: September 16, 2024

Expiration: September 15, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.